Effect of Remote Ischemic Preconditioning on Phosphorylated Protein Signaling in Children Undergoing Tetralogy of Fallot Repair: A Randomized Controlled Trial
Open Access
- 20 May 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 2 (3), e000095
- https://doi.org/10.1161/jaha.113.000095
Abstract
Background: Our previous randomized controlled trial demonstrated cardiorespiratory protection by remote ischemic preconditioning ( RIPC ) in children before cardiac surgery. However, the impact of RIPC on myocardial prosurvival intracellular signaling remains unknown in cyanosis. RIPC may augment phosphorylated protein signaling in myocardium and circulating leukocytes during tetralogy of F allot (ToF) repair. Methods and Results: Children (n=40) undergoing ToF repair were double‐blind randomized to RIPC (n=11 boys, 9 girls) or control (sham RIPC : n=9 boys, 11 girls). Blood samples were taken before, immediately after, and 24 hours after cardiopulmonary bypass. Resected right ventricular outflow tract muscle and leukocytes were processed for protein expression and mitochondrial respiration. There was no difference in age (7.1±3.4 versus 7.1±3.4 months), weight (7.7±1.8 versus 7.5±1.9 kg), or bypass or aortic cross‐clamp times between the groups (control versus RIPC , mean± SD ). No differences were seen between the groups for an increase in the ratio of phosphorylated to total protein for protein kinase B, p38 mitogen activated protein kinase, signal transducer and activator of transcription 3, glycogen synthase kinase 3β, heat shock protein 27, Connexin43, or markers associated with promotion of necrosis (serum cardiac troponin I), apoptosis (Bax, Bcl‐2), and autophagy (Parkin, Beclin‐1, LC3B). A high proportion of total proteins were in phosphorylated form in control and RIPC myocardium. In leukocytes, mitochondrial respiration and assessed protein levels did not differ between groups. Conclusions: In patients with cyanotic heart disease, a high proportion of proteins are in phosphorylated form. RIPC does not further enhance phosphorylated protein signaling in myocardium or circulating leukocytes in children undergoing ToF repair. Clinical Trial Registration: URL: ( http://www.anzctr.org.au/trial_view.aspx?id=335613 . Unique identifier: Australian New Zealand Clinical Trials Registry number ACTRN12610000496011.Keywords
This publication has 34 references indexed in Scilit:
- Increased myocardial methionine‐enkephalin with reduced arterial oxygenation in congenital heart diseaseJournal of Paediatrics and Child Health, 2014
- Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in HumansPLOS ONE, 2012
- The Beclin 1 network regulates autophagy and apoptosisCell Death & Differentiation, 2011
- Glycogen synthase kinase 3β transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K + channelsProceedings of the National Academy of Sciences of the United States of America, 2011
- Mechanism of Cardioprotection by Early Ischemic PreconditioningCardiovascular Drugs and Therapy, 2010
- Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass*Pediatric Critical Care Medicine, 2010
- Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Early and long-term prognostic value of Troponin-I after cardiac surgery in newborns and childrenEuropean Journal of Cardio-Thoracic Surgery, 2006
- Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical studyHeart, 2006
- Phosphorylation State of hsp27 and p38 MAPK During Preconditioning and Protein Phosphatase Inhibitor Protection of Rabbit CardiomyocytesJournal of Molecular and Cellular Cardiology, 1999